CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans.
CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans. Clin Cancer Res. 2011 Jun 15; 17(12):4101-9.